Degree of Joint Risk Factor Control and Incident Fracture Outcomes in Individuals With Type 2 Diabetes
Huan Huang1, Jie Cai1, Huaying Hu1
1Department of Epidemiology, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
Context:
Individuals with type 2 diabetes have a higher fracture risk than the general population. However, the association between joint risk factor control and fracture risk in this population remains unclear.
Objective:
To investigate the extent to which joint risk factor control might attenuate the excess risk of fracture outcomes in individuals with type 2 diabetes.
Methods:
We included 8935 individuals with type 2 diabetes and 35 740 matched controls without fractures at baseline from the UK Biobank (UKB), with a median follow-up of 12.1 years. Six modifiable risk factors were assessed: body mass index (BMI), physical activity, smoking, alcohol consumption, serum 25-hydroxyvitamin D (25(OH)D), and glycated hemoglobin A1c (HbA1c). Cox proportional hazards models were used to estimate associations between risk factor control and fracture risk.
Results:
Controlling each additional risk factor resulted in a 14% to 26% decrease in fracture risk. Optimal control (≥5 risk factors) correlated with a 50% reduction in overall fractures (HR 0.50; 95% CI 0.33-0.75). However, a 60% reduction in hip fractures (HR 0.40; 95% CI 0.16-0.98) was observed with the control of 4 risk factors. With control of 4 or more risk factors, fracture risk in individuals with type 2 diabetes was comparable to that of nondiabetic controls, and the protective effect was stronger in men than in women.
Conclusion:
Joint risk factor control was significantly linked to a reduced fracture risk, and optimal management may eliminate the excess fracture risk associated with type 2 diabetes.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...


